SQZB

0.02400.00%
IR

Ipsita Roymoulik

Senior Vice President of CMC & QUALITY

Ms. Ipsita Roymoulik, Ph.D., is Senior Vice President of CMC & QUALITY of SQZ Biotechnologies Company from 2022. Where she enabled adoption of rapid technologies to yield high cell therapy manufacturability (100%), full release of cell therapy product in 5-days and administration of 60+ batches of autologous product across 20 domestic/international clinical sites for 3 programs. She is Partner of CMC of Y Innovations Group. She has many years of CMC, Quality, and Compliance expertise supporting clinical development of oligonucleotide, RNA and cell therapy drugs as a Partner at the Firm leading the CMC, Quality, and Compliance Department. She served as the Director of Analytical Development at Moderna Therapeutics where she pioneered platform CMC approaches for the first 10 INDs and additionally initiated quality control and quality assurance functions for the company. She also supported and advised multiple clients on cutting-edge analytical technologies for over a decade at Nitto Denko Avecia. She was a 2021 Google Venture Impact List honoree. She has Ph.D. from University of Michigan, She attended Indian Institute of Technology, Kanpur and Presidency University.

Positions